Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06947746Not ApplicableRecruiting
HiSCs in the Treatment of Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
PrincipalinvestigatorStart date: 2025-05-01
NCT06373081Not ApplicableUnknown
Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease
ANCA Associated VasculitisAntiphospholipid SyndromeInflammatory Myopathy+3 more
Principalinvestigator
NCT07000292Phase 1/2Not Yet Recruiting
MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.
ANCA-Associated GlomerulonephritisLupus Nephritis (LN)
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Zhanguo Li

Peking University Institute of Rheuamotology and Immunology

Related
9 trials

Shared therapeutic areas:

MyositisAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAntiphospholipid Syndrome+1 more
Similarity Score13%

Qiubai Li, Professor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
7 trials

Shared therapeutic areas:

Rheumatoid Arthritis (RASystemic Lupus Erythematosus (Sle)
Similarity Score7%

He Huang, PhD

First Affiliated Hospital of Zhejiang University

Related
11 trials

Shared therapeutic areas:

Lupus NephritisSjogren's Syndrome
Similarity Score7%

Xinping Tian, MD

Peking Union Medical College Hospital

Related
7 trials

Shared therapeutic areas:

Lupus NephritisRheumatoid Arthritis (RA
Similarity Score7%

Zhihong Liu

Jinling Hospital, China

Related
2 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisLupus Nephritis
Similarity Score7%

Sarfaraz A Hasni, M.D.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Related
10 trials

Shared therapeutic areas:

Sjogren's SyndromeSystemic Lupus Erythematosus (Sle)
Similarity Score7%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score3%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Rheumatoid Arthritis (RA
Similarity Score3%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Sjogren's Syndrome
Similarity Score3%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Systemic Lupus Erythematosus (Sle)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06947746Not ApplicablePrincipalInvestigator

HiSCs in the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
Recruiting
NCT06373081Not ApplicablePrincipalInvestigator

Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease

ANCA Associated VasculitisAntiphospholipid SyndromeInflammatory Myopathy+3 more
Unknown
NCT07000292Phase 1/2PrincipalInvestigator

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

ANCA-Associated GlomerulonephritisLupus Nephritis (LN)
Not Yet Recruiting

All 3 trials loaded